Metabolites, 12(10), 954
Menopause is an aging process and an important time equivalent to one-third of a woman's lifetime. Menopause significantly increases the risk of cardiometabolic diseases, such as obesity, type 2 diabetes, cardiovascular diseases, non-alcoholic liver disease (NAFLD)/metabolic associated fatty liver disease (MFFLD), and metabolic syndrome (MetS). Women experience a variety of symptoms in the perimenopausal period, and these symptoms are distressing for most women. Many factors worsen a woman's menopausal experience, and controlling these factors may be a strategy to improve postmenopausal women's health. This review aimed to confirm the association between menopause and metabolic diseases (especially MetS), including pathophysiology, definition, prevalence, diagnosis, management, and prevention.
Jeong, H. G., & Park, H. (2022). Metabolic Disorders in Menopause. *Metabolites*, *12*(10), 954. https://doi.org/10.3390/metabo12100954
Jeong HG, Park H. Metabolic Disorders in Menopause. Metabolites. 2022;12(10):954. doi:10.3390/metabo12100954
Jeong, Hye Gyeong, and Hyuntae Park. "Metabolic Disorders in Menopause." *Metabolites*, vol. 12, no. 10, 2022, pp. 954.